Chai-2: The AI Model Accelerating Drug Discovery with Chai Discovery Co-Founders Jack Dent and Joshua Meier
AI has already fueled breakthroughs in biotechnology—but now, further advances in AI are poised to fuel pharmaceutical discoveries as well. Sarah Guo sits down with Joshua Meier and Jack Dent, co-founders of Chai Discovery, whose newly launched Chai-2 designs bespoke antibodies that bind to their targets at a…
We score an episode from what we can actually measure — its reach and engagement, what listeners say about it, and what it covers. We don't have those signals for this one yet, so it doesn't get a number.
Buzzmeter says it's buzzing across platforms — the Hive Vote says whether the people who actually listened liked it.
Rate this episode
Add your vote to the Hive — listeners rate every episode after they finish.
- No reviews yet — be the first.
More from No Priors: Artificial Intelligence | Technology | Startups
See all episodes →
43%From Restoring Sight to Reimagining the Brain, with Max Hodak
35%Redefining Chip Architecture with Arm CEO Rene Haas
33%Rethinking Legacy Data Infrastructure with Eon Co-Founders Ofir Ehrlich and Gonen Stein
Similar episodes from other shows
More like No Priors: Artificial Intelligence | Technology | Startups →
🔬The BioAI Phase Shift - Matthew McPartlon & Neil Patil, Chai Discovery
Learning the language of life
EP 32: AI Discovers Drugs: The 2026 Clinical Trial Moment for AI in Biotech
EP 27: AI Revolutionizing Drug Discovery (2023 - 2025)
One great episode in your inbox, daily — free.
One email a day, unsubscribe anytime. No spam, ever.